Category: "Medicine"

Precautions – Sudden Death Risk of Epilepsy

Precautions – Sudden Death Risk of Epilepsy

July 5, 2011 — People with epilepsy who are otherwise healthy are known to have a risk of unexplained sudden death that is more than 20 times higher than the general population. Doctors call it sudden unexpected death in epilepsy or SUDEP. However, that risk may be reduced by a variety of precautions, a new […]

SUDEP Recommendations

SUDEP Recommendations

Dr. Larry Hirsch and other investigators published a report of the National Institutes of Health Workshop on Sudden Unexpected Death in Epilepsy (SUDEP) in the May 31, 2011, issue of the journal Neurology. The report summarizes the discussions and recommendations of the workgroup including lessons learned from investigations of sudden infant death syndrome, sudden cardiac […]

NICE Preliminary Guidance Recommends Trobalt® (retigabine) For Adjunctive Treatment Of Partial Onset Epilepsy

NICE Preliminary Guidance Recommends Trobalt® (retigabine) For Adjunctive Treatment Of Partial Onset Epilepsy

Story from the U.K. The National Institute for Health and Clinical Excellence (NICE) has issued a Final Appraisal Determination (FAD), recommending retigabine as an option for the adjunctive (add-on) treatment of partial onset seizures with or without secondary generalisation* in adults aged 18 years and older with epilepsy, when previous treatment with other anti-epilepsy drugs […]

New Research Study on Most Effective Seizure Treatments for Children with Autism Spectrum Disorder

SAN DIEGO, May 24, 2011 – Roughly 25-35% of individuals with autism eventually develop seizures and many of the remainder have subclinical seizure-like brain activity. However, little is known about which traditional epilepsy treatments and commonly used non-traditional alternative treatments are effective for treating seizures or epilepsy in children and adults with autism spectrum disorder. […]

New First-in-class Treatment, Trobalt(R), Launched Today As An Adjunct Therapy In Patients With Difficult To Control Epilepsy

GlaxoSmithKline has today launched Trobalt® (retigabine), the first in a new class of anti-epileptic drug (AED), for the adjunct treatment of adults with partial-onset seizures, and demonstrated significant effects in a treatment resistant patient population.1 Retigabine is the first and currently only AED to target neuronal potassium channels1 which are involved in inhibitory mechanisms in […]

Medication Nonadherence Patterns Among Children With Epilepsy Associated With Socioeconomic Status

ScienceDaily (Apr. 26, 2011) — An examination of medication adherence among children with newly diagnosed epilepsy found that nearly 60 percent showed persistent nonadherence during the first 6 months of therapy, and that lower socioeconomic status was associated with higher non-adherence, according to a study in the April 27 issue of JAMA. Epilepsy, a disorder of recurrent […]

RECENT NEWS